NewAmsterdam Pharma Company NAMS Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
Based on trailing twelve months.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's free cash flow margin?
- NewAmsterdam Pharma Company (NAMS) reported free cash flow margin of -630.1% in Q1 2026.
- How has NewAmsterdam Pharma Company's free cash flow margin changed year-over-year?
- NewAmsterdam Pharma Company's free cash flow margin decreased by 111.1% year-over-year, from -298.5% to -630.1%.
- What is the long-term trend for NewAmsterdam Pharma Company's free cash flow margin?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's free cash flow margin has grown at a 301.4% compound annual growth rate (CAGR), from 10.2% to -657.8%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.